Keith, MA
Curtis Keith, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20080280863 | COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - The invention features methods and compositions for the treatment of immunoinflammatory disorders. | 11-13-2008 |
20100173881 | COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - The invention features methods and compositions for the treatment of immunonflammatory disorders. | 07-08-2010 |
20110223621 | COMBINATIONS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS - The invention features pharmaceutical compositions that include dipyridamole and a corticosteroid. | 09-15-2011 |
20120058979 | METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS - The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient a tetra-substituted pyrimidopyrimidine, either alone or in combination with one or more additional agents. The invention also features a composition containing a tetra-substituted pyrimidopyrimidine in combination with one or more additional agents. | 03-08-2012 |
20120095217 | FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF - Fluorinated compounds and methods of making fluorinated compounds are described herein. | 04-19-2012 |
20120149900 | FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF - Fluorinated compounds and methods of making fluorinated compounds are described herein. | 06-14-2012 |
Curtis T. Keith, Boston, MA US
Patent application number | Description | Published |
---|---|---|
20090075951 | Methods and Reagents for the Treatment of Inflammatory Disorders - The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering a tricyclic compound and, optionally, a corticosteroid or other compound to the patient. The invention also features a pharmaceutical composition containing a tricyclic compound and a corticosteroid or other compound for the treatment or prevention of an immunoinflammatory disorder. | 03-19-2009 |
David William Keith, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20150017706 | CAPTURED CARBON DIOXIDE FOR ALGACULTURE - Enhancing growth of algae in an algaculture facility includes contacting a growth medium with a gas including carbon dioxide, transferring some of the carbon dioxide to the growth medium to yield an enriched growth medium, and providing the enriched growth medium to the algaculture facility. The concentration of dissolved carbon dioxide in the enriched growth medium exceeds the concentration of dissolved carbon dioxide in the growth medium, where dissolved carbon dioxide includes ions formed by the reaction of carbon dioxide with a species in solution. The growth medium may be obtained from the algaculture facility, and may be filtered or otherwise processed before or after contacting the growth medium with the gas. Providing the enriched growth medium to the algaculture facility increases the concentration of dissolved carbon dioxide in the bulk growth medium of the algaculture facility. | 01-15-2015 |
Dennis Keith, Arlington, MA US
Patent application number | Description | Published |
---|---|---|
20080287347 | Novel Lipopeptides as Antibacterial Agents - The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel lipopeptide compounds and intermediates used in producing these compounds. | 11-20-2008 |
20090011977 | Novel Lipopeptides as Antibacterial Agents - The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel lipopeptide compounds and intermediates used in producing these compounds. | 01-08-2009 |
Dennis D. Keith, Arlington, MA US
Patent application number | Description | Published |
---|---|---|
20080213366 | Therapeutic Compositions - The present invention provides oral formulations of poorly bioavailable and/or poorly absorbable, and/or poorly water soluble therapeutic agents. The invention features pharmaceutical composition including a biopolymer, a therapeutic agent, for example an antimicrobial agent such as ceftriaxone, and an absorption enhancer, for example a polyoxyethylene alkyl ether absorption enhancer. Methods of making and using the pharmaceutical compositions is also described. | 09-04-2008 |
James Keith, Andover, MA US
Patent application number | Description | Published |
---|---|---|
20090191147 | Use of Interleukin-11 to Prevent Immune-Mediated Cytotoxicity - The use of interleukin-11 to prevent, to ameliorate, and to treat an immune-mediated disease in a mammal in need of such treatment is disclosed. | 07-30-2009 |
James C. Keith, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20100124536 | Hemophilia Treatment by Inhalation of Coagulation Factors - Hemophilia treatment by the inhalation of coagulation factors. Dry powder Factor IX is aerosolized to a mass median aerodynamic diameter of 4 μm or less, with at least 90% monomer content, at least 80% activity level, and 10% water or less. The aerosol is slowly, and deeply inhaled into the lung, and followed by a maximal exhale. | 05-20-2010 |
Laura Keith, Acton, MA US
Patent application number | Description | Published |
---|---|---|
20140246563 | METHODS AND APPARATUS FOR CALIBRATION OF A SENSOR ASSOCIATED WITH AN ENDOSCOPE - Embodiments of the invention include an apparatus including an enclosure configured to receive an endoscope having an electromagnetic radiation sensor. The apparatus also includes an electromagnetic radiation source having at least a portion disposed within the enclosure. The electromagnetic radiation source is configured to emit electromagnetic radiation based on a calibration instruction. The electromagnetic radiation sensor is configured to receive at least a portion of the electromagnetic radiation when at least a portion of the endoscope is coupled to the enclosure. | 09-04-2014 |